Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sigrid Carlsson

Showing results (11-20 of 93) with videos related to

Pageof 10
Sort By:
JAMA|May 8, 2019
Racial Disparities in Low-Risk Prostate CancerBehfar Ehdaie, Sigrid Carlsson, Andrew Vickers
Evidence-Based Medicine|January 14, 2011
Meta-analysis finds screening for prostate cancer with PSA does not reduce prostate cancer-related or all-cause mortality but results likely due to heterogeneity - the two highest quality studies identified do find prostate cancer-related mortality reductionsMonique J Roobol, Sigrid Carlsson, Jonas Hugosson
Nature Reviews. Urology|March 14, 2012
Prostate cancer: modeling the outcomes of prostate cancer screeningStacy Loeb, Sigrid Carlsson, R Scott Braithwaite
European Journal of Cancer (Oxford, England : 1990)|July 24, 2007
Anxiety associated with prostate cancer screening with special reference to men with a positive screening test (elevated PSA) - Results from a prospective, population-based, randomised studySigrid Carlsson, Gunnar Aus, Catrin Wessman, et al.
Annals of Internal Medicine|April 5, 2012
Screening for prostate cancerSigrid Carlsson, Andrew Vickers, Hans Lilja, et al.
European Urology|January 14, 2014
It ain't what you do, it's the way you do it: five golden rules for transforming prostate-specific antigen screeningAndrew Vickers, Sigrid Carlsson, Vincent Laudone, et al.
Lakartidningen|November 4, 2010
[Comments on the editorial on compulsory scrutiny of internship: regular quality assurance more important than centralized local]Sigrid Carlsson, Paulin Andréll, Ulla Strandman, et al.
BJU International|May 1, 2012
The absence of voiding symptoms in men with a prostate-specific antigen (PSA) concentration of ≥3.0 ng/mL is an independent risk factor for prostate cancer: results from the Gothenburg Randomized Screening TrialMaria Frånlund, Sigrid Carlsson, Johan Stranne, et al.
Deutsches Arzteblatt International|April 9, 2026
The Proposed Introduction of a Prostate Cancer Screening Program in Germany: Procedure, Necessary Studies before Implementation, Benefits, and RisksPeter Albers, Sigrid Carlsson, Agne Krilaviciute, et al.
European Urology Oncology|March 18, 2026
Introducing Key Performance Metrics for Assessing the Benefits and Harm of the Prostate Cancer Diagnostic PathwayAnwar R Padhani, Sigrid Carlsson, Ola Bratt, et al.
Pageof 10

Showing results (11-20 of 93) with videos related to

Sort By:
Pageof 10
JAMA|May 8, 2019
Racial Disparities in Low-Risk Prostate CancerBehfar Ehdaie, Sigrid Carlsson, Andrew Vickers
Evidence-Based Medicine|January 14, 2011
Meta-analysis finds screening for prostate cancer with PSA does not reduce prostate cancer-related or all-cause mortality but results likely due to heterogeneity - the two highest quality studies identified do find prostate cancer-related mortality reductionsMonique J Roobol, Sigrid Carlsson, Jonas Hugosson
Nature Reviews. Urology|March 14, 2012
Prostate cancer: modeling the outcomes of prostate cancer screeningStacy Loeb, Sigrid Carlsson, R Scott Braithwaite
European Journal of Cancer (Oxford, England : 1990)|July 24, 2007
Anxiety associated with prostate cancer screening with special reference to men with a positive screening test (elevated PSA) - Results from a prospective, population-based, randomised studySigrid Carlsson, Gunnar Aus, Catrin Wessman, et al.
Annals of Internal Medicine|April 5, 2012
Screening for prostate cancerSigrid Carlsson, Andrew Vickers, Hans Lilja, et al.
European Urology|January 14, 2014
It ain't what you do, it's the way you do it: five golden rules for transforming prostate-specific antigen screeningAndrew Vickers, Sigrid Carlsson, Vincent Laudone, et al.
Lakartidningen|November 4, 2010
[Comments on the editorial on compulsory scrutiny of internship: regular quality assurance more important than centralized local]Sigrid Carlsson, Paulin Andréll, Ulla Strandman, et al.
BJU International|May 1, 2012
The absence of voiding symptoms in men with a prostate-specific antigen (PSA) concentration of ≥3.0 ng/mL is an independent risk factor for prostate cancer: results from the Gothenburg Randomized Screening TrialMaria Frånlund, Sigrid Carlsson, Johan Stranne, et al.
Deutsches Arzteblatt International|April 9, 2026
The Proposed Introduction of a Prostate Cancer Screening Program in Germany: Procedure, Necessary Studies before Implementation, Benefits, and RisksPeter Albers, Sigrid Carlsson, Agne Krilaviciute, et al.
European Urology Oncology|March 18, 2026
Introducing Key Performance Metrics for Assessing the Benefits and Harm of the Prostate Cancer Diagnostic PathwayAnwar R Padhani, Sigrid Carlsson, Ola Bratt, et al.
Pageof 10